NOVAVAX INC Quarterly Costs and Expenses in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Novavax Inc quarterly/annual Costs and Expenses history and growth rate from Q1 2011 to Q3 2024.
  • Novavax Inc Costs and Expenses for the quarter ending September 30, 2024 was $219M, a 30.1% decline year-over-year.
  • Novavax Inc Costs and Expenses for the twelve months ending September 30, 2024 was $1.19B, a 29.2% decline year-over-year.
  • Novavax Inc annual Costs and Expenses for 2023 was $1.55B, a 41% decline from 2022.
  • Novavax Inc annual Costs and Expenses for 2022 was $2.63B, a 7.28% decline from 2021.
  • Novavax Inc annual Costs and Expenses for 2021 was $2.83B, a 217% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.19B $219M -$94.1M -30.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.28B $254M -$114M -31% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.4B $239M -$155M -39.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $1.55B $475M -$126M -21% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $1.68B $313M -$549M -63.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $2.23B $369M -$300M -44.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $2.53B $394M -$101M -20.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $2.63B $601M -$446M -42.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $3.07B $862M +$376M +77.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.7B $669M +$25M +3.89% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $2.67B $495M -$161M -24.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $2.83B $1.05B +$585M +126% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $2.25B $486M +$135M +38.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $2.11B $644M +$591M +1125% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $1.52B $656M +$630M +2396% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $892M $463M +$425M +1133% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $467M $351M +$333M +1906% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $134M $52.6M +$12.5M +31.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $121M $26.3M -$17.9M -40.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $139M $37.5M -$15.1M -28.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $154M $17.5M -$32.1M -64.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $187M $40M -$12.7M -24.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $199M $44.2M -$8.96M -16.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $208M $52.6M -$5.56M -9.55% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $214M $49.6M -$345K -0.69% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $214M $52.8M +$4.56M +9.47% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $210M $53.2M +$6.66M +14.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $203M $58.2M -$1.25M -2.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-11
Q3 2017 $204M $50M -$16.6M -24.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $221M $48.2M -$30.8M -39% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $251M $46.5M -$33M -41.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $284M $59.4M -$25.3M -29.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 $310M $66.5M +$26.8M +67.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $283M $79M +$44.2M +127% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $239M $79.5M +$45.3M +132% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $193M $84.8M +$46.4M +121% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $147M $39.7M +$11.7M +41.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $135M $34.8M +$8.71M +33.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $127M $34.2M +$12.3M +56.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $114M $38.4M +$15.4M +66.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $99M $28M +$7.92M +39.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $91M $26.1M +$9.68M +58.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $81.4M $21.8M +$8.01M +57.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $73.3M $23M +$8.94M +63.6% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $64.4M $20.1M +$7.47M +59.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $56.9M $16.4M +$3.47M +26.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $53.5M $13.8M +$1.73M +14.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $51.7M $14.1M +$3.96M +39.1% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $47.8M $12.6M +$3.64M +40.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $44.1M $13M +$4.04M +45.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $40.1M $12.1M +$3.85M +46.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $36.3M $10.1M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-12
Q3 2011 $8.98M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $8.92M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $8.26M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.